Gender
Female
Location
Mumbai, Maharashtra
Birthday:
July 21
I am...
Teacher
My research field or area of interest innanotechnology
Drug delivery
Interest in...
Nanoformulations
Publication list
1. Joshi R, Kulkarni YA, Wairkar S*. Pharmacokinetic, pharmacodynamic and formulations aspects of Naringenin: An update. Life sciences. 2018, 215: 43-56. (Impact factor-3.2) 2. Sridhar V, Gaud R, Bajaj A, Wairkar S*. Pharmacokinetics and pharmacodynamics of intranasally administered selegiline nanoparticles with improved brain delivery in Parkinson's disease. Nanomedicine: Nanotechnology, Biology and Medicine. 2018 Nov 1;14(8):2609-18. (Impact factor-6.5) 3. Bhandari MS, Wairkar SM, Patil US, Jadhav NR. Co-amorphization of Ibuprofen by Paracetamol for Improved Processability, Solubility, and In vitro Dissolution. Acta Chimica Slovenica. 2018 Sep 17;65(3):492-501. (Impact factor-1.02) 4. R Rajput, S Wairkar*, R Gaud. Nutraceuticals for better management of osteoporosis: An overview. Journal of Functional Foods. 2018 Aug 31; 47: 480-90. (Impact factor-3.47) 5. Ruhi Raj, S Wairkar*, Vinay Sridhar, Ram Gaud; Pramipexole dihydrochloride loaded chitosan nanoparticles for nose to brain delivery: Development, characterization and in vivo anti-Parkinson activity; International Journal of Biological Macromolecules; Volume 109, 1 April 2018, Pages 27–35. (Impact factor-3.67). 6. Sridhar V, S Wairkar*, R Gaud, A Bajaj, P Meshram. Brain targeted delivery of Mucoadhesive Thermosensitive Nasal Gel of Selegiline Hydrochloride for treatment of Parkinson's disease. Journal of Drug Targeting. 2018 Feb 7; 26(2):150-61. (Impact factor-3.08). 7. S. Wairkar* and R.S. Gaud, N.R. Jadhav. Enhanced dissolution and bioavailability of Nateglinide by microenvironmental pH-regulated ternary solid dispersion: In-vitro and in-vivo evaluation; Journal of Pharmacy and Pharmacology; Early online on 7 June 2017. (Impact factor-2.4). 8. S. Wairkar* and R.S. Gaud. Co-amorphous combination of Nateglinide-Metformin hydrochloride for dissolution enhancement. AAPS PharmSciTech. 2016 Jun 1;17(3):673-81. (Impact factor- 2.45). 9. Varghese A, Saboo P, S Wairkar*, Bioactivity guided fractionation of methanolic extract of Terminalia arjuna for its CYP3A and CYP2D inhibition in rat liver microsomes. Biopharmaceutics & drug disposition. 2018 Jan 12. (Impact factor 2.07) 10. Gauravi Raut, S Wairkar*, Management of psoriasis with nutraceuticals: An update, Complementary Therapies in Clinical Practice 31, May 2018, Pages 25-30 (Impact factor-1.47). 11. S. Wairkar* and R.S. Gaud, Adhithi Raghavan. Multi-particulate Systems: Cutting-edge Technology for Controlled Drug Delivery. Recent Patents on Drug Delivery & Formulation. 2016 Dec 1;10(3):184-91. 12. S. Wairkar* and R.S. Gaud. Formulation and In-vitro Characterization of Sustained Release Matrix Pellets of Nateglinide. International Journal of Pharmaceutical Sciences and Research. 2016 Jul 1;7(7):2925. 13. S. Wairkar* and R.S. Gaud. Solid dispersions: Solubility enhancement technique for poorly soluble drugs. International Journal of Research in Pharmaceutical and Biomedical Sciences. 2013 Jul–Sep;4(3):847-854. 14. R. Godbole, M. Invally, S. Wairkar, G. Kaur Formulation, Development and Evaluation of a Novel Polymer-based Anti-Inflammatory Emulgel of Aceclofenac. Science International; 2018; 6: 71-79 15. S. Wairkar*, A. Ambike and A. Paradkar; characterization of cashew nut gum as a binder in tablet formulation; international journal of pharmaceutical research; 2012, volume 4, issue 4, 95-98. 16. V. Patel, A. Raghavan and S. Wairkar*. Effect of Natural Penetration Enhancers on Formulation of Ibuprofen Topical Gel, Journal of Scientific Research in Pharmacy, Vol. 4 Iss. 2 (April – June,2015) :61-65
Researchgroup, Institute, University, School, Company name
SPPSPTM, SVKMs NMIMS, Mumbai
The network creator will send periodical messages to members - you below to allow us to email you
yes
